Cargando…

TB and SIV Coinfection; a Model for Evaluating Vaccine Strategies against TB Reactivation in Asian Origin Cynomolgus Macaques: A Pilot Study Using BCG Vaccination

This pilot study aimed to determine the utility of a cynomolgus macaque model of coinfection with simian immunodeficiency virus (SIV) for the assessment of vaccines designed to prevent reactivation of TB. Following infection caused by aerosol exposure to an ultralow dose of Mycobacterium tuberculosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	White, Andrew D., Sibley, Laura, Gullick, Jennie, Sarfas, Charlotte, Clark, Simon, Fagrouch, Zahra, Verschoor, Ernst, Salguero, Francisco J., Dennis, Mike, Sharpe, Sally
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473354/ https://www.ncbi.nlm.nih.gov/pubmed/34579182 http://dx.doi.org/10.3390/vaccines9090945

Ejemplares similares

Characterization of the Infant Immune System and the Influence and Immunogenicity of BCG Vaccination in Infant and Adult Rhesus Macaques
por: Sarfas, Charlotte, et al.
Publicado: (2021)

IV BCG Vaccination and Aerosol BCG Revaccination Induce Mycobacteria-Responsive γδ T Cells Associated with Protective Efficacy against M. tb Challenge
por: Morrison, Alexandra L., et al.
Publicado: (2023)

Protective Efficacy of Inhaled BCG Vaccination Against Ultra-Low Dose Aerosol M. tuberculosis Challenge in Rhesus Macaques
por: White, Andrew D., et al.
Publicado: (2020)

Antibody glycosylation correlates with disease progression in SIV‐ Mycobacterium tuberculosis coinfected cynomolgus macaques
por: Haycroft, Ebene R, et al.
Publicado: (2023)

Differences in host immune populations between rhesus macaques and cynomolgus macaque subspecies in relation to susceptibility to Mycobacterium tuberculosis infection
por: Sibley, Laura, et al.
Publicado: (2021)

Evaluation of the Immunogenicity of Mycobacterium bovis BCG Delivered by Aerosol to the Lungs of Macaques
por: White, A. D., et al.
Publicado: (2015)

Vaccination with intravenous BCG protects macaques with pre-existing SIV infection from tuberculosis
por: Larson, Erica C., et al.
Publicado: (2023)

SIV Evolutionary Dynamics in Cynomolgus Macaques during SIV-Mycobacterium tuberculosis Co-Infection
por: Tisthammer, Kaho H., et al.
Publicado: (2021)

Hypothetical endogenous SIV-like antigens in Mauritian cynomolgus macaques
por: Li, Hongzhao, et al.
Publicado: (2018)

Cynomolgus macaque IL37 polymorphism and control of SIV infection
por: Shiina, Takashi, et al.
Publicado: (2019)

Neonatal BCG vaccination and child survival in TB-exposed and TB-unexposed children: a prospective cohort study
por: Thysen, Sanne M, et al.
Publicado: (2020)

Commentary: Bettering BCG: a tough task for a TB vaccine?
por: Srivastava, Brahm S., et al.
Publicado: (2019)

Need for BCG Vaccination to Prevent TB in High-Incidence Countries and Populations
por: Pooransingh, Shalini, et al.
Publicado: (2020)

TB infection and BCG vaccination: are we protected from COVID-19?
por: Madan, M., et al.
Publicado: (2020)

Vaccination with BCGΔBCG1419c protects against pulmonary and extrapulmonary TB and is safer than BCG
por: Aceves-Sánchez, Michel de Jesús, et al.
Publicado: (2021)

Natural and cross-inducible anti-SIV antibodies in Mauritian cynomolgus macaques
por: Li, Hongzhao, et al.
Publicado: (2017)

MTBVAC vaccination protects rhesus macaques against aerosol challenge with M. tuberculosis and induces immune signatures analogous to those observed in clinical studies
por: White, Andrew D., et al.
Publicado: (2021)

Evaluation of early innate and adaptive immune responses to the TB vaccine Mycobacterium bovis BCG and vaccine candidate BCGΔBCG1419c
por: Gunasena, Manuja, et al.
Publicado: (2022)

Determination of the Pharmacokinetics and Pharmacodynamics of Isoniazid, Rifampicin, Pyrazinamide and Ethambutol in a Cross-Over Cynomolgus Macaque Model of Mycobacterium tuberculosis Infection
por: Sibley, Laura, et al.
Publicado: (2022)

‘Fight TB with BCG’: Mass Vaccination Campaigns in the British Caribbean, 1951–6
por: Altink, Henrice
Publicado: (2014)

761. Age-Related Incidence of TB Infection Supporting Efficacy of BCG Vaccination
por: Sweeney, Eileen, et al.
Publicado: (2018)

Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2009)

High-dose Mycobacterium tuberculosis aerosol challenge cannot overcome BCG-induced protection in Chinese origin cynomolgus macaques; implications of natural resistance for vaccine evaluation
por: Sibley, Laura, et al.
Publicado: (2021)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2011)

Engineering new mycobacterial vaccine design for HIV–TB pediatric vaccine vectored by lysine auxotroph of BCG
por: Saubi, Narcís, et al.
Publicado: (2014)

A protective, single-visit TB vaccination regimen by co-administration of a subunit vaccine with BCG
por: Dijkman, Karin, et al.
Publicado: (2023)

Improve protective efficacy of a TB DNA-HSP65 vaccine by BCG priming
por: Gonçalves, Eduardo DC, et al.
Publicado: (2007)

Preclinical Development of an In Vivo BCG Challenge Model for Testing Candidate TB Vaccine Efficacy
por: Minassian, Angela M., et al.
Publicado: (2011)

Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques
por: White, Andrew D., et al.
Publicado: (2022)

BCG Vaccine Protection against TB Infection among Children Older than 5 Years in Close Contact with an Infectious Adult TB Case
por: Syggelou, Angeliki, et al.
Publicado: (2020)

Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine
por: Gupta, Nancy, et al.
Publicado: (2018)

Effect of Gender on Clinical Presentation of Tuberculosis (TB) and Age-Specific Risk of TB, and TB-Human Immunodeficiency Virus Coinfection
por: Humayun, Maheen, et al.
Publicado: (2022)

Strategy to Better Select HIV-Infected Individuals for Latent TB Treatment in BCG-Vaccinated Population
por: Yang, Chin-Hui, et al.
Publicado: (2013)

Early Potent Protection against Heterologous SIVsmE660 Challenge Following Live Attenuated SIV Vaccination in Mauritian Cynomolgus Macaques
por: Berry, Neil, et al.
Publicado: (2011)

Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques
por: Li, Hongzhao, et al.
Publicado: (2018)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
por: Pathan, Ansar A., et al.
Publicado: (2012)

An aerosol challenge model of tuberculosis in Mauritian cynomolgus macaques
por: Sharpe, S. A., et al.
Publicado: (2017)

Protection in Macaques Immunized with HIV-1 Candidate Vaccines Can Be Predicted Using the Kinetics of Their Neutralizing Antibodies
por: Davis, David, et al.
Publicado: (2011)

The TB vaccine development pathway – An innovative approach to accelerating global TB vaccine development
por: Roordink, Danielle, et al.
Publicado: (2021)

Ending the TB pandemic: the urgency of a new and improved TB vaccine and the World Health Organization's TB Vaccine Accelerator Council
por: Adepoju, Victor Abiola, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u649s6u66l0epqec0qhp06j3r2